Exagen Inc (XGN)
2.42
-0.03
(-1.22%)
USD |
NASDAQ |
Sep 29, 16:00
2.44
+0.02
(+0.83%)
After-Hours: 20:00
Exagen Cash from Financing (TTM): -10.50M for June 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | -10.50M |
March 31, 2023 | -0.521M |
December 31, 2022 | -0.489M |
September 30, 2022 | -0.529M |
June 30, 2022 | -0.382M |
March 31, 2022 | -0.428M |
December 31, 2021 | 64.68M |
September 30, 2021 | 64.81M |
June 30, 2021 | 64.76M |
March 31, 2021 | 65.04M |
December 31, 2020 | -0.097M |
September 30, 2020 | -1.806M |
June 30, 2020 | 61.38M |
Date | Value |
---|---|
March 31, 2020 | 65.21M |
December 31, 2019 | 68.73M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
December 31, 2015 | 10.61M |
September 30, 2015 | 7.264M |
June 30, 2015 | 7.874M |
March 31, 2015 | 4.975M |
December 31, 2014 | 8.284M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-10.50M
Minimum
Jun 2023
68.73M
Maximum
Dec 2019
29.32M
Average
-0.097M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
Fonar Corp | -7.572M |
XWELL Inc | -10.99M |
ProPhase Labs Inc | -10.99M |
Applied DNA Sciences Inc | -- |
OncoCyte Corp | 11.62M |